Tumor suppressors in Zebrafish: From TP53 to PTEN and beyond

Advances in Experimental Medicine and Biology

Volumn 916, Issue , 2016, Pages 87-101

  den Hertog, Jeroen ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Apc; Pten; Tp53; Tumor suppressor; Vhl; Zebrafish

Indexed keywords

APC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN P53; RIBOSOME PROTEIN; VON HIPPEL LINDAU PROTEIN;

DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; ZEBRA FISH; ANIMAL; DISEASE MODEL; GENETICS; MUTATION; NEOPLASM;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, P53; GENES, TUMOR SUPPRESSOR; MUTATION; NEOPLASMS; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEINS; ZEBRAFISH;

EID: 84979034967     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-30654-4_4     Document Type: Chapter

References (77)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
2. Sherr CJ (2004) Principles of tumor suppression. Cell 116:235–246
3. Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8:353–367
4. Feitsma H, Cuppen E (2008) Zebrafish as a cancer model. Mol Cancer Res 6:685–694
5. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323–331
6. Vousden KH (2000) p53: death star. Cell 103:691–694
7. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310
8. Vousden KH, Lu X (2002) Live or let die: the cell’s response to p53. Nat Rev Cancer 2:594–604
9. Storer NY, Zon LI (2010) Zebrafish models of p53 functions. Cold Spring Harb Perspect Biol 2:a001123
10. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL et al (2005) tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A 102:407–412
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr et al (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221
12. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S et al (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1–7
13. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF et al (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249–254
14. Dovey M, White RM, Zon LI (2009) Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish 6:397–404
15. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U (1998) N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 111:757–761
16. Omholt K, Platz A, Kanter L, Ringborg U, Hansson J (2003) NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 9:6483–6488
17. Santoriello C, Gennaro E, Anelli V, Distel M, Kelly A et al (2010) Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One 5, e15170
18. Langenau DM, Keefe MD, Storer NY, Guyon JR, Kutok JL et al (2007) Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 21:1382–1395
19. Xia SJ, Pressey JG, Barr FG (2002) Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 1:97–104
20. Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH et al (2013) Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS One 8, e76951
21. Mudbhary R, Hoshida Y, Chernyavskaya Y, Jacob V, Villanueva A et al (2014) UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 25:196–209
22. Gutierrez A, Snyder EL, Marino-Enriquez A, Zhang YX, Sioletic S et al (2011) Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A 108:16386–16391
23. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S et al (2004) Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 101:12792–12797
24. Rhodes J, Amsterdam A, Sanda T, Moreau LA, McKenna K et al (2009) Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol 29:5911–5922
25. Kim SH, Speirs CK, Solnica-Krezel L, Ess KC (2011) Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin. Dis Model Mech 4:255–267
26. Kim SH, Kowalski ML, Carson RP, Bridges LR, Ess KC (2013) Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish. Dis Model Mech 6:925–933
27. Shive HR, West RR, Embree LJ, Azuma M, Sood R et al (2010) brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc Natl Acad Sci U S A 107: 19350–19355
28. Shive HR, West RR, Embree LJ, Golden CD, Hickstein DD (2014) BRCA2 and TP53 collaborate in tumorigenesis in zebrafish. PLoS One 9, e87177
29. Shin J, Padmanabhan A, de Groh ED, Lee JS, Haidar S et al (2012) Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Dis Model Mech 5:881–894
30. Stokoe D (2001) Pten. Curr Biol 11:R502
31. Hollander MC, Blumenthal GM, Dennis PA (2011) PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11:289–301
32. Li DM, Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124–2129
33. Li J, Yen C, Liaw D, Podsypanina K, Bose S et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947
34. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 91:1922–1932
35. Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R et al (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333–334
36. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67
37. Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ et al (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73:404–411
38. Di Cristofano A, Pesce B, Cordon-Cardo C, PandolfiPP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19:348–355
39. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M et al (1999) Mutation of Pten/ Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563–1568
40. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T et al (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169–1178
41. Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C et al (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42:454–458
42. Zhang S, Yu D (2010) PI(3)king apart PTEN’s role in cancer. Clin Cancer Res 16:4325–4330
43. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375–13378
44. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP et al (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 95:13513–13518
45. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C et al (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39
46. Song MS, Salmena L, PandolfiPP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13:283–296
47. Croushore JA, Blasiole B, Riddle RC, Thisse C, Thisse B et al (2005) Ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Dev Dyn 234:911–921
48. Faucherre A, Taylor GS, Overvoorde J, Dixon JE, Hertog J (2008) Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 27:1079–1086
49. Choorapoikayil S, Kuiper RV, de Bruin A, den Hertog J (2012) Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma. Dis Model Mech 5:241–247
50. Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu S et al (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med 208:1595–1603
51. Choorapoikayil S, Weijts B, Kers R, de Bruin A, den Hertog J (2013) Loss of Pten promotes angiogenesis and enhanced vegfaa expression in zebrafish. Dis Model Mech 6:1159–1166
52. Choorapoikayil S, Kers R, Herbomel P, Kissa K, den Hertog J (2014) Pivotal role of Pten in the balance between proliferation and differentiation of hematopoietic stem cells in zebrafish. Blood 123:184–190
53. Dong ZW, Ren CG, Xia Y, Su D, Du TT et al (2014) Pten regulates homeostasis and inflammation- induced migration of myelocytes in zebrafish. J Hematol Oncol 7:17
54. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170
55. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480
56. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C et al (1994) A targeted chaintermination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 91:8969–8973
57. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J et al (2003) The Wnt/betacatenin pathway regulates cardiac valve formation. Nature 425:633–637
58. Paridaen JT, Danesin C, Elas AT, van de Water S, Houart C et al (2009) Apc1 is required for maintenance of local brain organizers and dorsal midbrain survival. Dev Biol 331:101–112
59. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, van den Born M et al (2006) Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 7:444–449
60. Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT et al (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137:623–634
61. Valvezan AJ, Huang J, Lengner CJ, Pack M, Klein PS (2014) Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1) in mice and zebrafish. Dis Model Mech 7:63–71
62. Kaelin WG (2005) The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing. Cold Spring Harb Symp Quant Biol 70:159–166
63. Haase VH (2005) The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting. Semin Cell Dev Biol 16:564–574
64. van Rooijen E, Voest EE, Logister I, Korving J, Schwerte T et al (2009) Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia. Blood 113:6449–6460
65. van Rooijen E, Voest EE, Logister I, Bussmann J, Korving J et al (2010) von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish. Dis Model Mech 3:343–353
66. Santhakumar K, Judson EC, Elks PM, McKee S, Elworthy S et al (2012) A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. Cancer Res 72:4017–4027
67. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT et al (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2, E139
68. MacInnes AW, Amsterdam A, Whittaker CA, Hopkins N, Lees JA (2008) Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A 105:10408–10413
69. Provost E, Bailey JM, Aldrugh S, Liu S, Iacobuzio-Donahue C et al (2014) The tumor suppressor rpl36 restrains KRAS(G12V)-induced pancreatic cancer. Zebrafish 11:551–559
70. Taylor AM, Humphries JM, White RM, Murphey RD, Burns CE et al (2012) Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp Hematol 40:228–237.e5
71. van der Velden YU, Wang L, Zevenhoven J, van Rooijen E, van Lohuizen M et al (2011) The serine-threonine kinase LKB1 is essential for survival under energetic stress in zebrafish. Proc Natl Acad Sci U S A 108:4358–4363
72. Gjini E, Mansour MR, Sander JD, Moritz N, Nguyen AT et al (2015) A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing. Mol Cell Biol 35:789–804
73. Reischauer S, Levesque MP, Nusslein-Volhard C, Sonawane M (2009) Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis. PLoS Genet 5, e1000720
74. Gyda M, Wolman M, Lorent K, Granato M (2012) The tumor suppressor gene retinoblastoma- 1 is required for retinotectal development and visual function in zebrafish. PLoS Genet 8, e1003106
75. van Rooijen E, Giles RH, Voest EE, van Rooijen C, Schulte-Merker S et al (2008) LRRC50, a conserved ciliary protein implicated in polycystic kidney disease. J Am Soc Nephrol 19:1128–1138
76. Basten SG, Davis EE, Gillis AJ, van Rooijen E, Stoop H et al (2013) Mutations in LRRC50 predispose zebrafish and humans to seminomas. PLoS Genet 9, e1003384
77. Albacker CE, Storer NY, Langdon EM, Dibiase A, Zhou Y et al (2013) The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish. PLoS One 8, e64969